|
The whys and hows of rituximab in thyroid eye disease
ModernMedicine “Immunobiologic agents are used early in patients with thyroid eye disease,” said Simeon Lauer, MD, clinical associate professor, Albert Einstein College of Medicine, Bronx, NY. “In most cases when an immunologic agent is thought to be needed, it is not. |
Passing on the right antibodies: Protecting piglets from diarrhoeaScience CodexLike human babies, new-born piglets have only poorly developed immune systems, although their resistance to disease is generally thought to be extremely important to their s…
|
The US Clinical Research Market Outlook to 2017 – Led by Aging Population …
DigitalJournal.com The new drugs such as laquinimod, teriflunomide and dimethyl fumarate, and three mAbs— alemtuzumab, daclizumab and rituximab are anticipated to mask the effects and remit the occurrence of multiple sclerosis” – according to the research report ‘The US … |
|
Cell Therapeutics’ Pixuvri gets French marketing nod to treat aggressive B …
pharmabiz.com The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled phase III clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have … |
BioNews TexasUT Southwestern Researchers Determine Rituximab Safely Treated RA Patients …BioNews TexasRituximab, one of the first chimeric monoclonal antibody therapies, was developed in the mid 1990s for the treatment of disorders such as Hematologi…
|
SeraCare Acquires Reagents and Antibodies Supplier KPL
GenomeWeb NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has acquired Kirkegaard & Perry Laboratories, a supplier of antibodies and reagents for the life science research and diagnostics markets. Among the products offered by … SeraCare Life Sciences Acquires KPLSan Francisco Chronicle (press release) Linden-Backed SeraCare Acquires Kirkegaard & Perry LabsDow Jones Bankruptcy & Debt (registration) |
New antibodies estimate risk of polyps developing into bowel cancerNews-Medical.netPolyps in the mucosa of the colon are a common finding during screening colonoscopies. Some sub-groups of polyps are classed as precursors of bowel cancer. Until now, it…
|
Children’s Cancer Recovery Foundation Reveals New Antibodies that May Fight …
DigitalJournal.com The article explains that they “have developed two monoclonal antibodies called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.” The antibodies bind to different molecules in the immune system and stimulate its response in … |
|
Children’s Cancer Recovery Foundation Reveals New Antibodies that May Fight …
EIN News (press release) The article explains that they “have developed two monoclonal antibodies called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.” The antibodies bind to different molecules in the immune system and stimulate its response in … |
|
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma …
The Herald | HeraldOnline.com The European Medicines Agency’s (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled Phase 3 clinical trial, which compares PIXUVRI-rituximab to gemcitabine-rituximab in patients who … CELL THERAPEUTICS INC : Market Access Granted in France for Aggressive …4-traders (press release) |